MORTIMER IAN
CIK: 0001619961•PRESIDENT & CEO
OfficerDirector
Primary company: Xenon Pharmaceuticals Inc. (XENE)
MORTIMER IAN is a corporate insider (PRESIDENT & CEO) at Xenon Pharmaceuticals Inc. (XENE) filing SEC Form 4 transactions. 55 transactions, totaling $76,165 in purchases and $5,675,807 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Purchase | 30,000 | $37.38 | $1.12M | 49,923 | 9/30/2026 Filed: 9/30/2026 | Filing → | |
| Sale | 7,308 | $55.23 | $404K | 19,923 | 3/13/2026 Filed: 3/12/2026 | Filing → | |
| Exercise | 12,500 | - | - | 37,500 | 3/12/2026 Filed: 3/12/2026 | Filing → | |
| Exercise | 12,500 | - | - | 27,231 | 3/12/2026 Filed: 3/12/2026 | Filing → | |
| Sale | 2,010 | $46.32 | $93K | 6,000 | 12/8/2025 Filed: 12/9/2025 | Filing → | |
| Sale | 8,820 | $45.59 | $402K | 8,010 | 12/8/2025 Filed: 12/9/2025 | Filing → | |
| Sale | 14,375 | $45.03 | $647K | 16,830 | 12/5/2025 Filed: 12/9/2025 | Filing → | |
| Sale | 97 | $45.01 | $4K | 31,205 | 11/28/2025 Filed: 12/3/2025 | Filing → | |
| Exercise | 25,000 | - | - | 0 | 10/1/2025 Filed: 10/1/2025 | Filing → | |
| Sale | 25,000 | $40.16 | $1.00M | 31,302 | 10/1/2025 Filed: 10/1/2025 | Filing → | |
| Exercise | 25,000 | $7.69 | $192K | 56,302 | 10/1/2025 Filed: 10/1/2025 | Filing → | |
| Award | 50,000 | - | - | 50,000 | 3/12/2025 Filed: 3/13/2025 | Filing → | |
| Award | 275,000 | $35.48 | $9.76M | 275,000 | 3/12/2025 Filed: 3/13/2025 | Filing → | |
| Exercise | 16,315 | $17.76 | $290K | 0 | 1/27/2025 Filed: 1/27/2025 | Filing → | |
| Sale | 1,149 | $41.07 | $47K | 31,302 | 1/27/2025 Filed: 1/27/2025 | Filing → | |
| Exercise | 1,149 | $17.76 | $20K | 32,451 | 1/27/2025 Filed: 1/27/2025 | Filing → | |
| Sale | 15,166 | $40.46 | $614K | 31,302 | 1/27/2025 Filed: 1/27/2025 | Filing → | |
| Exercise | 15,166 | $17.76 | $269K | 46,468 | 1/27/2025 Filed: 1/27/2025 | Filing → | |
| Exercise | 22,468 | $17.76 | $399K | 16,315 | 1/24/2025 Filed: 1/27/2025 | Filing → | |
| Sale | 22,468 | $40.20 | $903K | 31,302 | 1/24/2025 Filed: 1/27/2025 | Filing → |
Type
Purchase
Shares
30,000
Price
$37.38
Value
$1.12M
Type
Sale
Shares
7,308
Price
$55.23
Value
$404K
Type
Exercise
Shares
12,500
Price
-
Value
-
Type
Exercise
Shares
12,500
Price
-
Value
-
Type
Sale
Shares
2,010
Price
$46.32
Value
$93K
Type
Sale
Shares
8,820
Price
$45.59
Value
$402K
Type
Sale
Shares
14,375
Price
$45.03
Value
$647K
Type
Sale
Shares
97
Price
$45.01
Value
$4K
Type
Exercise
Shares
25,000
Price
-
Value
-
Type
Sale
Shares
25,000
Price
$40.16
Value
$1.00M
Type
Exercise
Shares
25,000
Price
$7.69
Value
$192K
Type
Award
Shares
50,000
Price
-
Value
-
Type
Award
Shares
275,000
Price
$35.48
Value
$9.76M
Type
Exercise
Shares
16,315
Price
$17.76
Value
$290K
Type
Sale
Shares
1,149
Price
$41.07
Value
$47K
Type
Exercise
Shares
1,149
Price
$17.76
Value
$20K
Type
Sale
Shares
15,166
Price
$40.46
Value
$614K
Type
Exercise
Shares
15,166
Price
$17.76
Value
$269K
Type
Exercise
Shares
22,468
Price
$17.76
Value
$399K
Type
Sale
Shares
22,468
Price
$40.20
Value
$903K
AI Agent
Try asking...